![Ben Kouakou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ben Kouakou
Directeur/Membre du Conseil chez
SymbioFCell SA
Profil
Ben Kouakou is currently a Director at SymbioFCell SA. Prior to this, he worked as an Investment Analyst at PC Associés SAS from 2014 to 2018.
Postes actifs de Ben Kouakou
| Sociétés | Poste | Début |
|---|---|---|
SymbioFCell SA
 SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems | Directeur/Membre du Conseil | - |
Anciens postes connus de Ben Kouakou
| Sociétés | Poste | Fin |
|---|---|---|
PC Associés SAS
 PC Associés SAS Investment ManagersFinance IPSA is an active manager focused on science-based companies within the European Union. They invest internationally in the ICT, life sciences, natural resources and energy sectors, particularly in France, the UK, Germany, the Netherlands and Denmark. They target high-growth businesses with innovative technology and an experienced management team with a proven track record of growth. They seek board representation, actively participate in strategic decisions, and aim to build their portfolio companies into market leaders. The firm prefers to be the lead or co-lead investor and invests between EUR 1-5 million per round, participating in successive financing rounds. They invest across development stages from startups to pre-IPO companies, and accompany their portfolio companies throughout their development. They favor companies with disruptive products or technology which have reached an advanced stage of development, are likely to generate significant revenues within two to three years, and have exit visibility through IPO or trade sale. In the life sciences sector, IPSA focuses on clinical-stage drug development, medical devices, drug delivery and development services. Their ICT investments are in domains including content, software, enabling technology and infrastructure. The firm also invests in the energy and natural resources sector, focusing on exploration and production, as well as on renewable energy and clean technology. | Analyste en capital-investissement | 31/12/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PC Associés SAS
PC Associés SAS Investment ManagersFinance IPSA is an active manager focused on science-based companies within the European Union. They invest internationally in the ICT, life sciences, natural resources and energy sectors, particularly in France, the UK, Germany, the Netherlands and Denmark. They target high-growth businesses with innovative technology and an experienced management team with a proven track record of growth. They seek board representation, actively participate in strategic decisions, and aim to build their portfolio companies into market leaders. The firm prefers to be the lead or co-lead investor and invests between EUR 1-5 million per round, participating in successive financing rounds. They invest across development stages from startups to pre-IPO companies, and accompany their portfolio companies throughout their development. They favor companies with disruptive products or technology which have reached an advanced stage of development, are likely to generate significant revenues within two to three years, and have exit visibility through IPO or trade sale. In the life sciences sector, IPSA focuses on clinical-stage drug development, medical devices, drug delivery and development services. Their ICT investments are in domains including content, software, enabling technology and infrastructure. The firm also invests in the energy and natural resources sector, focusing on exploration and production, as well as on renewable energy and clean technology. | Finance |
SymbioFCell SA
SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems | Producer Manufacturing |
Choisissez Zonebourse 
